| Calcitriol supplementation in Nonalcoholic Fatty Liver Disease | Effect of Calcitriol supplementation on the severity of fatty liver, inflammatory and metabolic biomarkers in patients with non-alcoholic fatty liver with different genotypes of vitamin D receptor | IRCT2017053034222N1 |
| Oral Calcitriol With Ketoconazole in CRPC | A Phase II Study of Oral Calcitriol in Combination With Ketoconazole in Castration Resistant Prostate Cancer, Progressing Despite Primary ADT and Abiraterone | NCT03261336 |
| Effect of calcitriol on delayed progression of nonalcoholic fatty liver disease by inhibiting oxidative stress in the liver | Effect of calcitriol on delayed progression of nonalcoholic fatty liver disease by inhibiting oxidative stress in the liver | ChiCTR-OOC-17012909 |
| stroke treatment | Therapeutic effects of calcitriol on inflammatory markers and improvement of neurological symptoms in stroke patients | IRCT2017012532174N1 |
| Does Preoperative Calcium and Calcitriol Decrease Rates of Post Thyroidectomy Hypocalcemia? | Does Preoperative Calcium and Calcitriol Decrease Rates of Post Thyroidectomy Hypocalcemia? | NCT03869398 |
| Calcitriol Monotherapy for X-Linked Hypophosphatemia | Calcitriol Monotherapy for X-Linked Hypophosphatemia: Effects on Mineral Ions, Growth and Skeletal Parameters | NCT03748966 |
| Evaluation of the Effect of Calcitriol on the Percutaneous Coronary Intervention | Evaluation of the Effects of Calcitriol on Ischemia-reperfusion Injury and Inflammatory Biomarkers in Patients Undergoing Percutaneous Coronary Intervention (PCI) | IRCT20151227025726N10 |
| Vitamin D in Sepsis - A Randomised Control Trial | Calcitriol in Sepsis Patients - A Randomised Control Trial - CalSARCT | CTRI/2019/01/017066 |
| calcirtiol effect in contrast induced nephropathy | Study of effect of calcitriol in preventing contrast induced nephropathy among patients with kidney dysfunction undergoing coronary angiography or interventions | IRCT20160412027346N7 |
| Evaluation of effect of different type of vitamin D on biochemical markers of osteopenia of Prematurity | Comparison of Calcitriol and Cholecalciferol on biochemical markers of Metabolic Bone Disease in very low birth weight infants | IRCT20111206008307N28 |
| Topical Rapamycin and Calcitriol for Angiofibroma of Tuberous Sclerosis | Study of Combination Therapy With Topical Rapamycin and Calcitriol for Cutaneous Lesions of Tuberous Sclerosis: A Double-blind Randomized Controlled Trial | NCT03140449 |
| Safety Study of an Oral Vitamin D Analog in Postmenopausal Women | A Phase 1B, Double-Blind, Placebo-Controlled, Calcitriol Active-Controlled, Daily-Dose, Escalating-Dose, Safety and Tolerance Study of 2MD Soft Gel Capsules in Normal Healthy Postmenopausal Women | NCT01969656 |
| Effect of 1,25-dihydroxyvitamin D3 (calcitriol) on mortality of in-hospital sepsis/septic shock patients | Effect of 1,25-dihydroxyvitamin D3 (calcitriol) on mortality of in-hospital sepsis/septic shock patients | TCTR20161101004 |
| Evaluation of the effects of Calcitriol on acute kidney injury | Evaluation of the efficacy of Calcitriol treatment on acute kidney injury improvement | IRCT2016022326716N1 |
| Effects of calcitriol on the complications of hematopoietic stem cell transplantation | The effects of calcitriol on the incidence rate and severity of oral mucositis in patients undergoing autologous hematopoietic stem cell transplantation: a double-blind, randomized clinical trial | IRCT2016052727435N2 |
| Effects of calcitriol on the complications of hematopoietic stem cell transplantation | Effects of oral calcitriol versus placebo on hematologic and immunologic reconstitution after autologous hematopoietic stem cell transplantation: a double-blind, randomized clinical trial | IRCT2015120816837N2 |
| A multicenter, randomized, double blind, parallel group, vehicle controlled, study of the safety and efficacy of calcitriol 3 mcg/g ointment applied twice daily for 8 weeks in pediatric subjects (2 to 12 years of age) with mild to moderate plaque psoriasis | A multicenter, randomized, double blind, parallel group, vehicle controlled, study of the safety and efficacy of calcitriol 3 mcg/g ointment applied twice daily for 8 weeks in pediatric subjects (2 to 12 years of age) with mild to moderate plaque psoriasis - Safety and Efficacy study of calcitriol 3 mcg/g ointment in pediatric subjects with plaque psoriasis | EUCTR2014-001744-38-DE |
| Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis | A multicenter open label uncontrolled study of the long term safety and efficacy of calcitriol 3 mcg/g ointment applied twice daily for 26 weeks in pediatric subjects (2 to 16 years and 11 months of age) with mild to moderate plaque psoriasis - LTS and efficacy study of calcitriol 3 mcg/g ointment in pediatric subjects with plaque psoriasis | EUCTR2014-000710-53-DE |
| Plaque Psoriasis Study in Pediatric Subjects | A Multicenter, Randomized, Double Blind, Parallel Group, Vehicle Controlled, Study of the Safety and Efficacy of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 8 Weeks in Pediatric Subjects (2 to 12 Years of Age) With Mild to Moderate Plaque Psoriasis | NCT02186665 |
| Effect of Calciterol and Cinacalcate on hyperparathyroidism | A Comparative Study on the Effect of Calcitriol and Cinacalcet on Hyperparathyroidism in ESRD Patients | IRCT20190702044076N1 |
| Calcitriol in prevention of mucositis in patients with Fanconi anemia undergoing Hematopoietic Stem Cell Transplantation | Efficacy of calcitriol in prevention of high dose chemotherapy induced mucositis in patients with Fanconi anemia undergoing Hematopoietic Stem Cell Transplantation | IRCT201307141030N15 |
| Calcitriol in Preventing Lung Cancer in High-Risk Patients | A Pilot Study of Oral Calcitriol in Patients at High Risk for Lung Cancer | NCT01896804 |
| Therapeutic effect of vitamin D on renal manifestation of systemic lupus erythematosus | The effect of calcitriol on progress and activity of Lupus nephritis | IRCT2013030912762N1 |
| Oral Calcitriol for Reduction of Mild Proteinuria in Patients With CKD | Phase 4 Study of Oral Calcitriol for Reduction of Mild Proteinuria in Patients With CKD | NCT01820832 |
| PK and PD Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis | Pharmacokinetics and Pharmacodynamics of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 14 Days Under Conditions of Maximal Use in Pediatric Subjects (2 to 12 Years of Age) With Plaque Psoriasis | NCT01766440 |
| Effect of Calcitriol on Microalbuminuria in Diabetes Patients | Effect of Calcitriol on Microalbuminuria in Diabetes Mellitus type 2 | IRCT2016091429812N1 |
| The influences of paclitaxel, calcitriol and cinacalcet on hemodialysis patients with CKD-MBD in real-world | The influences of paclitaxel, calcitriol and cinacalcet on hemodialysis patients with CKD-MBD in real-world | ChiCTR1900026679 |
| A clinical Study to understand the effects and safety profile of Test drug [Ingredients - Calcium Carbonate, Calcitriol, Magnesium, Soy Isoflavones, and Vitamin K2-7] versus Comparator drug [Ingredients - Calcium Carbonate, Calcitriol and Zinc] in Postmenopausal Women with Osteoporosis. | A Prospective, Randomized, Open-label, Parallel-group Investigator-initiated Study to Compare the Efficacy and Safety of Supplementation with Capsules of Calcium Carbonate, Calcitriol in Combination with Magnesium, Soy Isoflavones, and Vitamin K2-7 versus Capsules of Calcium Carbonate, Calcitriol in Combination with Zinc in Postmenopausal Women with Osteoporosis | CTRI/2022/07/043913 |
| To find out effect of Injection Zoledronic acid for treatment of bone weakening condition in patients having long term liver problems/damage. | Efficacy and safety of zoledronic acid as add on therapy to calcitriol in patients of osteoporosis with liver cirrhosis | CTRI/2020/03/024247 |
| Assessment of malnutrition in patients with ulcerative colitis and effect of supplementation of Calcitriol in patients with active disease. | Assessment of prevalence and predictors of micronutrient deficiency in patients with ulcerative colitis and the effect of supplementation of active vitamin D in patients with Active Ulcerative Colitis â?? a double blind randomized placebo-controlled trial. | CTRI/2021/03/031675 |
| Calcitriol combined with ergocalciferol in CKD with proteinuria | A Double-blind ,randomized,placebo-controlled trial of calcitriol combined with ergocalciferol in CKD with proteinuria | TCTR20140929002 |
| Assessment of the effect of topical calcitriol on Chronic Rhinosinusitis | Assessment of the effect of topical calcitriol on Chronic Rhinosinusitis with and without polyps | IRCT201705173186N11 |
| Calcitriol Plus Paclitaxel in Treating Patients With Advanced Solid Tumors | A Phase I Trial Of Oral Calcitriol [1,25-(OH)2D3] And Paclitaxel In Advanced Solid Tumors | NCT00009802 |
| A clinical trial to study the effects and safety of two creams, calcitriol and adapalene, in patients with mild and moderate acne. | Comparative Efficacy of Topical Calcitriol versus Topical Adapalene in the Treatment of Mild and Moderate Acne: A Randomized controlled trial - NIL | CTRI/2024/12/077823 |
| Investigating the safety, tolerability and immune modulation of a novel treatment for stage 3 type one diabetes and help preserve remaining beta cells. | A phase 1, randomised, double-blind, placebo-controlled, single-dose and multi-dose escalation study to investigate the safety, tolerability and pharmacodynamics of subcutaneously administered proinsulin peptide/calcitriol liposomes (ASITI-201) in stage 3 Type 1 Diabetes. | ACTRN12624001043527 |
| The dose of preoperative calcitriol to prevent postoperative hypocalcemia after parathyroidectomy in end stage kidney disease : a randomized controlled clinical trial | The dose of preoperative calcitriol to prevent postoperative hypocalcemia after parathyroidectomy in end stage kidney disease : a randomized controlled clinical trial | TCTR20240315002 |
| the effect of rosuvastatin and calcitriol in total thyroidectomy | the effect of rosuvastatin and calcitriol on vocal function of total thyroidectomy patients: a randomized clinical trial | IRCT20230711058741N1 |
| Effect of calcitriol combined with calcium carbonate capsules on the efficacy, bone mineral density, electrolyte metabolism and safety of patients with diabetic osteoporosis | Effect of calcitriol combined with calcium carbonate capsules on the efficacy, bone mineral density, electrolyte metabolism and safety of patients with diabetic osteoporosis | ChiCTR2400079635 |
| Effect of calcitriol on post-percutaneous nephrolithotomy inflammation | The effect of preoperative calcitriol on inflammatory markers following percutaneous nephrolithotomy (PCNL): a randomized controlled trial | IRCT20230815059154N1 |
| Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosis | Comparison of the Efficacy and Safety With Eldecalcitol and Calcitriol in Postmenopausal Women With Low Bone Mineral Density or Mild Osteoporosis | NCT05902078 |
| A multicenter phase ? clinical study on the effect of pre-operative supplementation of calcitriol and calcium in preventing hypocalcemia in patients undergoing total thyroidectomy and bilateral central compartment neck dissection | A multicenter phase ? clinical study on the effect of pre-operative supplementation of calcitriol and calcium in preventing hypocalcemia in patients undergoing total thyroidectomy and bilateral central compartment neck dissection - EPOC study | ChiCTR2300071168 |
| Comparison of the efficacy and safety between eldecalcitol and calcitriol in postmenopausal women with low bone mineral density and mild osteoporosis | Comparison of the efficacy and safety between eldecalcitol and calcitriol in postmenopausal women with low bone mineral density and mild osteoporosis | ChiCTR2300070456 |
| Effect Of Calcitriol On Neutrophil To Lymphocytes Ratio And High Sensitivity C-Reactive Protein Covid-19 Patients | Effect Of Calcitriol On Neutrophil To Lymphocytes Ratio And High Sensitivity C-Reactive Protein Covid-19 Patients | NCT05765617 |
| Effect of Phosphate Binders on FGF-23 With Concurrent Calcitriol | Effect of Phosphate Binders on FGF-23 During Calcitriol Administration in CKD Stage 3 Patients | NCT01748396 |
| Comparison of two topical vitamin D analogues in form of ointments in combination with phototherapy in treatment of psoriasis | Comparative evaluation of topical calcipotriol plus Narrow Band ultraviolet B phototherapy versus topical calcitriol plus Narrow Band ultraviolet B phototherapy in treatment of psoriasis - Calcipotriol vs calcitriol with NBUVB in psoriasis treatment | CTRI/2022/06/043333 |
| Calcitriol Supplementation in COVID-19 Patients | A Randomized Open Label Study to Evaluate Efficacy of Calcitriol Supplementation in COVID-19 Patients With Vitamin D Deficiency | NCT05415254 |
| A clinical study on the effect of pre-operative supplementation of calcitriol and calcium in preventing hypocalcemia in patients receiving total thyroidectomy plus bilateral central compartment neck dissection | A Phase II clinical study on the effect of pre-operative supplementation of calcitriol and calcium in preventing hypocalcemia in patients receiving total thyroidectomy plus bilateral central compartment neck dissection | ChiCTR2200059815 |
| Effect of oral calcitriol pulse therapy in comparison with oral daily calcitriol method in hemodiyalis paitients | Comparison the effect of oral calcitriol pulse therapy with oral daily calcitriol method in hemodiyalis paitients | IRCT20111024007892N10 |
| Double-blind Randomized Controlled Trial Investigating the Effects of Calcitriol on Biomarkers in Diabetic Kidney Disease Patients | Effects of Calcitriol on Podocytes in Diabetic Kidney Disease Patients: Assessment of Urine Podocin, Urine Nephrin, Urine Interleukin-6, Urine KIM-1, Plasma Renin, and Albuminuria | NCT05298163 |
| Evaluation of the effects of calcium supplementation alone and with calcitriol in preventing the symptoms of hypocalcemia following total or near total thyroidectomy | Evaluation of the prophylactic effects of oral calcium supplement alone and with calcitriol in the development of symptomatic hypocalcemia after total or near-total thyroidectomy | IRCT20210513051285N1 |
| Calcium+Calcitriol Versus PTH for the Prevention of Hypocalcemia in Thyroidectomy. Randomized Clinical Trial | Comparison of Routine Prophylactic Calcium + Calcitriol and Selective Use Based on PTH for the Prevention of Postoperative Hypocalcemia in Patients With Total Thyroidectomy. Randomized Clinical Trial | NCT05252884 |
| Effect of Clcitriol in Ischemi stroke | Comparison between calcitriol and placebo on serum interleukin 6 level, stroke severity, infarct volume and clinical outcomes in patients with ischemic stroke | IRCT20210101049905N2 |
| Evaluation of the Effects of Calcitriol's in the Neurological Symptoms of Friedreich's Ataxia Patients | Pilot Trial About the Effects of Calcitriol's Treatment in the Neurological Function and Frataxin's Level in Friedreich's Ataxia Patients | NCT04801303 |
| Effect of Clcitriol in Ischemi stroke | Evaluating the effect of calcitriol on serum level of inflammatory biomarkers in patients with ischemic stroke | IRCT20210101049905N1 |
| A clinical trial to study effect of local injection of vitamin D3 on rate of tooth movement in patients undergoing fixed orthodontic treatment. | â?? EVALUATION OF EFFECTIVENESS OF LOCALLY INJECTED CALCITRIOL IN ALTERING RATE OF ORTHODONTIC TOOTH MOVEMENT DURING CANINE RETRACTION â?? RANDOMISED CONTROLLED CLINICAL TRIAL â?? | CTRI/2020/09/027568 |
| Efficacy of Cinacalcet in the Treatment of Secondary Hyperparathyroidism | The Evaluation of the Efficacy of Calcitriol Compared to Calcitriol plus Cinacalcet in the Treatment of Severe Secondary Hyperparathyroidism in Hemodialysis Patients Referred to Dialysis Centers in Gorgan | IRCT20200218046533N1 |
| comparison of effectiveness and safety of topical sequential therapy with tazarotene and calcitriol with monotherapy of calcitriol or tazarotene in patients with stable plaque psoriasis. | To compare the safety and efficacy of sequential therapy with topical tazarotene and calcitriol versus monotherapy of tazarotene and calcitriol in patients with stable plaque psoriasis | CTRI/2020/03/023715 |
| Management of Mineral and Bone Disease in Hemodialysis-Calcitriol vs. Paricalcitol | A Randomized, Prospective, Cross-Over Study of Calcitriol vs. Paricalcitol in the Treatment of Mineral and Bone Disease in Hemodialysis Patients | NCT01725113 |
| Efficacy and Safety of Alfacalcidol Compared to Calcitriol for Treatment of Secondary Hyperparathyroidism | A Randomized Trial Comparing Pulse Calcitriol and Alfacalcidol for the Treatment of Secondary Hyperparathyroidism in Hemodialysis Patients | NCT01115543 |
| Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for the Treatment of Chemotherapy-Induced Alopecia | Phase I Dose-Escalation Study, to Evaluate the Safety, Tolerability and Pharmacokinetics of a Topical Compound 31543 (Calcitriol, USP) in Adult Cancer Patients Receiving Taxane-based Chemotherapy Regimens for the Treatment of Advanced or Recurrent Disease | NCT01588522 |
| Calcitriol in the Treatment of Immunoglobulin A (IgA) Nephropathy | The Safety and Short-Term Efficacy of Calcitriol in the Treatment of Immunoglobulin A Nephropathy | NCT00319761 |
| Phase I/II Study of High-Dose Calcitriol Plus Temodar for Patients With Metastatic Melanoma | A Phase I/II Study of High-Dose Calcitriol in Combination With Temozolomide for Patients With Metastatic Melanoma | NCT00301067 |
| Efficacy Study of Targeted, Local Delivery of Drugs to Treat Crohn's Disease | Pilot, Open-Label, Randomized, Parallel Group Study to Evaluate Clinical/ and Immunological Efficacy/Safety of Locally Delivered 6-MP or Calcitriol vs Purinethol in Non-Steroid Dependent Patients With Active CD | NCT00287170 |
| Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004 | A Continuation Study of DN-101 (Calcitriol) and Docetaxel in Subjects Previously Enrolled in Studies DN101-002 or DN101-004 | NCT00285675 |
| DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (AIPC Study of Calcitriol Enhancing Taxotere [ASCENT-2]) | A Phase 3, Randomized, Open-Label Study Evaluating DN-101 in Combination With Docetaxel in Androgen-Independent Prostate Cancer (AIPC) (ASCENT-2) | NCT00273338 |
| Calcitriol, Ketoconazole, and Dexamethasone in Treating Patients With Metastatic or Unresectable Solid Tumors | A Phase I Study of Oral Calcitriol in Combination With Ketoconazole in Refractory Advanced Malignancies | NCT00238225 |
| Calcitriol and Docetaxel in Treating Patients With Metastatic or Locally Advanced Pancreatic Cancer | Phase II Study of Calcitriol-Enhanced Docetaxel in Patients With Previously Untreated Metastatic or Locally Advanced Pancreatic Cancer | NCT00238199 |
| Calcitriol, Mitoxantrone, and Prednisone in Treating Patients With Metastatic Prostate Cancer | Phase II Study of DN-101 (High Dose Pulse Calcitriol), Mitoxantrone, Prednisone in Androgen-Independent Prostate Cancer (AIPC) | NCT00182741 |
| CLINICAL STUDY OF APPRAISAL OF THE EFFECTIVENESS OF 1,25 (OH)2D3 (CALCITRIOL) TOWARDS PLACEBO IN THE DIABETES OF TYPE 1 OF RECENET INSORGENCE (IMDIAB XIII) | CLINICAL STUDY OF APPRAISAL OF THE EFFECTIVENESS OF 1,25 (OH)2D3 (CALCITRIOL) TOWARDS PLACEBO IN THE DIABETES OF TYPE 1 OF RECENET INSORGENCE (IMDIAB XIII) | EUCTR2005-000751-15-IT |
| Calcitriol in Preventing Prostate Cancer in Patients With Prostatic Intraepithelial Neoplasia | A Randomized Phase II Trial Of Calcitriol In Patients With Prostatic Intraepithelial Neoplasia | NCT00118066 |
| Calcitriol and Gefitinib With or Without Dexamethasone in Treating Patients With Advanced Solid Tumors | A Phase I Study of Intravenous (IV) Calcitriol in Combination With ZD1839 (IRESSA®) in Refractory Solid Tumors | NCT00084708 |
| Calcitriol and Dexamethasone Before Radical Prostatectomy in Treating Patients With Localized Adenocarcinoma (Cancer) of the Prostate | A Pilot Trial of Calcitriol in Localized Prostate Cancer: Investigation of Biologic Effects and Potential Intermediate Endpoints | NCT00084864 |
| Study of High-Dose Pulse Administration DN-101 (Calcitriol) in Patients With Myelodysplastic Syndrome (MDS) | A Phase 2, Multicenter, Open Label Study of the Safety and Efficacy of High-Dose Pulse Administration DN-101 (Calcitriol) in Patients With Myelodysplastic Syndrome | NCT00057031 |
| Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer Who Have Undergone Surgery or Radiation Therapy | Calcitriol + Dexamethasone in Early, Recurrent Prostate Cancer Following Local Therapy, A Phase I/II Trial | NCT00054522 |
| ASCENT: Androgen Independent Prostate Cancer Study of Calcitriol Enhancing Taxotere | A Phase 2/3 Multicenter, Randomized, Double Blind Study of Docetaxel (Taxotere) Plus DN-101 or Placebo in Androgen Independent Prostate Cancer (AIPC) | NCT00043576 |
| Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes | Calcitriol and Dexamethasone for Myelodysplastic Syndromes | NCT00030069 |
| Calcitriol and Carboplatin in Treating Patients With Stage IV Prostate Cancer That Has Not Responded to Hormone Therapy | Phase II Study of Calcitrol Enhanced Carboplatin in Hormone Refractory Prostate Cancer | NCT00017576 |
| Calcitriol Plus Dexamethasone in Treating Patients With Prostate Cancer That Has Not Responded to Hormone Therapy | Phase I Study Of Oral, 1,25 Dihydroxycholecalciferol (Calcitriol) + Dexamethasone In Hormone-refractory Prostate Cancer | NCT00010231 |
| Calcitriol Plus Carboplatin in Treating Patients With Advanced Solid Tumors | A Phase I Trial of Subcutaneous And/Or Oral Calcitriol [(1,25-COH)2D3] and Carboplatin in Advanced Solid Tumors | NCT00008086 |
| Study of Topical Calcitriol in Children With Psoriasis | | NCT00006275 |
| Calcitriol and Zoledronate in Treating Patients With Progressive Prostate Cancer | A Phase I Study of 1,25 Dihydroxy-Vitamin D3 (Calcitriol) in Patients With Prostate Cancer | NCT00004928 |
| Calcitriol in Treating Patients With a Rising PSA Level Following Treatment for Prostate Cancer | Phase II Study of Pulse Calcitriol in Patients With Rising PSA After Definitive Treatment for Prostate Cancer | NCT00004043 |
| Study of Topical Calcitriol or Oral Calcitriol in Patients With Psoriasis | | NCT00004468 |
| Effect of active vitamin D (calcitriol) on left ventricular hypertrophy in type 2 diabetic patients with chronic kidney disease. | Effect of active vitamin-D treatment on left ventricular hypertrophy in patients with type-2 diabetes and stage-3 chronic kidney disease. - VItamin D in left VentrIcular hypertrophy Diabetes (VIVID) Trial. | EUCTR2011-003025-10-GB |
| Bone Mass and Strength After Kidney Transplantation | A Comparative Trial of Calcitriol Versus Placebo for the Preservation of Bone Mass and Strength After Kidney Transplantation | NCT02224144 |
| Is the efficacy of nutritional vitamin D (cholecalciferol) comparable to active vitamin D (calcitriol) as maintenance therapy in dialysis dependent chronic kidney disease patients? | Is the efficacy of nutritional vitamin D (cholecalciferol) comparable to active vitamin D (calcitriol) as maintenance therapy in dialysis dependent chronic kidney disease patients? | ACTRN12616000108415 |
| Calcitriol and cholecalciferol effect on cardiac biomarkers | the comparison of Effect of calcitriol and cholecalciferol on cardiac biomarkers in patients undergoing elective percutaneous coronary intervention, a randomized controlled study | IRCT20150518022306N3 |
| Acceleration of Orthodontic Tooth Movement | Evaluation of Clinical Efficacy of Locally Injected Vitamin D3 (Calcitriol or 1,25 Dihidroxicolecalciferol) in Accelerating Orthodontic Tooth Movement (A Randomized Controlled Trial) | NCT05560919 |
| MAL DL-PDT and Calcitriol for AK treatment of the upper extremities | A randomized half-side comparative study of Methyl aminolevulinate (MAL, Metvix®) Daylight photodynamic therapy (DL-PDT) with or without pre-treatment with calcitriol (Silkis®) for Actinic Keratosis (AK) of the upper extremities - MAL DL-PDT and Calcitriol for AK treatment of the upper extremities | EUCTR2018-000545-39-IT |
| A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer | A Phase II Trial of Calcitriol and Naproxen in Patients With Recurrent Prostate Cancer | NCT00383487 |
| A Study of Calcitriol BID Topical Treatment in Adolescents With Plaque Psoriasis | PK and PD of Calcitriol Following Twice Daily Application of Calcitriol 3 µg/g Ointment Under Conditions of Maximal Use in Adolescents With Plaque Psoriasis | NCT00419666 |
| CLINICAL EFFICACY EVALUATION OF A FIXED COMBINATION OF CALCITRIOL 3 µg/g WITH THREE CONCENTRATIONS (100, 250, 500µg/g) OF CLOBETASOL PROPIONATE AS SPRAY FORMULATION USING THE MODIFIED DUMAS-SCHOLTZ PSORIASIS MINI PLAQUE TEST UNDER NON-OCCLUSIVE CONDITIONS | CLINICAL EFFICACY EVALUATION OF A FIXED COMBINATION OF CALCITRIOL 3 µg/g WITH THREE CONCENTRATIONS (100, 250, 500µg/g) OF CLOBETASOL PROPIONATE AS SPRAY FORMULATION USING THE MODIFIED DUMAS-SCHOLTZ PSORIASIS MINI PLAQUE TEST UNDER NON-OCCLUSIVE CONDITIONS | EUCTR2006-006487-32-FR |
| The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent Proteinuria | The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent Proteinuria | NCT00508898 |
| Effect of calcitriol in PCOS | Comparison of calcitriol and metformin treatment on improvement of clinical and metabolic complications of polycystic ovary syndrome | IRCT201108074167N4 |
| Anti-proteinuric Effect of Calcitriol in Non-diabetic Kidney Disease Patients | Additive Renoprotective Effects of Oral Calcitriol in Nondiabetic Chronic Kidney Disease Patients | NCT01512862 |
| A clinical trial to study the efficacy of daily versus twice weekly therapy with oral calcitriol for controlling secondary hyperparathyroidsim in pre-dialysis CKD patients. | An open, randomised, prospective study to evaluate the efficacy of pulse oral versus daily Calcitriol therapy for controlling secondary hyperparathyroidism in pre-dialysis CKD patients - A pilot study. | CTRI/2011/12/002263 |
| To study the use of calcitriol in reducing protein in urine in patients with kidney damage due to proteinuria. | Antiproteinuric Effect of Oral Calcitriol in chronic Proteinuric Nephropathy:A randomized controlled trial. | CTRI/2011/10/002086 |
| Clinical Trial of 0.0003% Calcitriol, 0.1% Tacrolimus, and Petrolatum for the Treatment of Pityriasis Alba | A Double Blind Randomized Trial, Placebo-controled of 0.0003% Calcitriol Ointment Versus 0.1% Tacrolimus Ointment in the Treatment of Pityriasis Alba | NCT01388517 |
| Oral Paricalcitol versus Calcitriol in Peritoneal Dialysis Patients: effects on peritoneal transport and peritoneal defence | Oral Paricalcitol versus Calcitriol in Peritoneal Dialysis Patients: effects on peritoneal transport and peritoneal defence - Paricalcitol in PD | NL-OMON37926 |
| Effects of High Dose Calcitriol in Breast Cancer Patients | A Pilot Study of the Effects of High-Dose Oral Calcitriol in Breast Cancer Patients Prior to Surgery | NCT01293682 |
| Paricalcitol Versus Calcitriol for the Management of Renocardiac Syndrome in Renal Transplant Patients | Phase 4 Study of Paricalcitol and Calcitriol for Reparative Management of Chronic Allograft Dysfunction and Renocardiac Syndrome in Vitamin D Insufficient Renal Transplant Recipients | NCT01265615 |
| Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers | Additive Renoprotective Effects of Oral Calcitriol in IgA Nephropathy Patients Taking Renin-Angiotensin System Blockers | NCT01237028 |
| Evaluation of the effect of calcitriol supplementation on diabetes control and its complications in hyperlipidemic patients with type 2 diabetes mellitus, Shiraz, 2009 | Evaluation of the effect of calcitriol supplementation on glucose, insulin, hemoglobin A1C, lipid profile and oxidative stress markers in hyperlipidemic patients with type 2 diabetes mellitus, Shiraz, 2009 | IRCT138806282480N1 |
| Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance | Calcitriol or Placebo in Men for Prostate Cancer Active Surveillance | NCT00482157 |
| Cinacalcet and concurrent intravenous calcitriol for treatment of secondary hyperparathyroidism in dialysis patients compared with intravenous calcitriol alone | Cinacalcet and concurrent intravenous calcitriol for treatment of secondary hyperparathyroidism in dialysis patients compared with intravenous calcitriol alone - Comparison of cinacalcet and concurrent intravenous calcitriol with calcitriol alone | JPRN-UMIN000003438 |
| Calcitriol, Cisplatin, and Gemcitabine Hydrochloride in Treating Patients With Advanced Solid Tumors That Cannot Be Removed by Surgery | A Phase I Clinical Trial of Oral Calcitriol With Fixed Dose of Cisplatin and Gemcitabine in Patients With Advanced Solid Tumors | NCT01093092 |
| Calcitriol in Advanced Intrahepatic Cholangiocarcinoma | A Clinical Trial Phase II of Calcitriol in Combination With 5-fluorouracil, Mitomycin C and Leucovorin in an Open Label-non-randomized Study to Evaluate the Tumor Response in Patients With Advanced Intrahepatic Cholangiocarcinoma | NCT01039181 |
| Randomized Controlled Trial of Calcitriol vs. Placebo Among Critically-ill Patients With Sepsis | Randomized Controlled Trial of Calcitriol vs. Placebo Among Critically-ill Patients With Sepsis | NCT01689441 |
| The Pharmacokinetics of Rocaltrol When Administered Alone or in Combination With Fosrenol or Renvela in Healthy Volunteers | A Phase I, Randomized, Open-Label, Three Period Cross-Over Study to Assess the Pharmacokinetics of Oral Calcitriol (ROCALTROL®) in Healthy Volunteers When Administered Alone or When Co-Administered With Lanthanum Carbonate (FOSRENOL®) or Sevelamer Carbonate (RENVELA®) | NCT00925704 |
| Calcitriol, Physical Activity, and Bone Health in Cancer Survivors | A Pilot Study of the Effects of High-Dose Oral Calcitriol and Physical Activity on Bone Health in Breast Cancer Survivors | NCT00904033 |
| Calcitriol in the Treatment of Immunoglobulin A Nephropathy | | NCT00862693 |
| Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3/4 Chronic Kidney Disease (CKD) With Secondary Hyperparathyroidism (SHPT) | A Phase 4 Randomized Multicenter Open Label Trial of Paricalcitol Versus Calcitriol for Efficacy and Safety in Stage 3 or 4 Ckd Patients With Secondary Hyperparathyroidism | NCT00823303 |
| Safety and Efficacy Study of Paricalcitol Versus Calcitriol in the Treatment of Secondary Hyperparathyroidism | A Multi Centre, Open Label, Parallel Group, Randomized Controlled Trial to Compare the Safety and Efficacy of Oral Paricalcitol Versus Oral Calcitriol in the Treatment of Secondary Hyperparathyroidism in Dialysis Patients | NCT00800358 |
| Phase I/II Calcitriol in Lung Cancer | A Phase I/II Clinical Trial of Intravenous (IV) Calcitriol With Fixed Dose of Cisplatin and Docetaxel in Advanced Non-Small Cell Lung Cancer | NCT00794547 |
| Vitamin D and Coronary Calcification Study | A Phase IV, Randomized, Single-center Study of the Effects of Calcitriol and Paricalcitol on Vascular Calcification in Chronic Kidney Disease Stages 3 and 4 | NCT00752102 |
| Calcitriol in Preventing Lung Cancer in Smokers and Former Smokers at High Risk of Lung Cancer | A Pilot Study of Oral Calcitriol in Patients at High Risk for Lung Cancer | NCT00690924 |
| Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects | Efficacy and Safety of Paricalcitol on the Treatment of Secondary Hyperparathyroidism in Calcitriol Resistant Dialysis Subjects | NCT00664430 |
| Vitamin D and COPD | Clinical trial for comparing the effect of 25(oh)2vitD, calcitriol and placebo on pulmonary function test, serum C reactive protein and total antioxidant in patient with chronic obstructive pulmonary disease. | IRCT138712271774N1 |
| Safety & Effectiveness of Clobex Spray, Followed by Calcitriol Ointment in Management of Plaque Psoriasis | A Multi-Center, Open-Label Study to Evaluate the Safety and Efficacy of a Consecutive Treatment Regimen of Clobetasol Propionate 0.05% Spray, Followed by Calcitriol Ointment 3µg/g, in the Management of Moderate to Severe Plaque Psoriasis | NCT00658788 |
| Bioequivalency Study of Calcitriol Tablets Under Fasting Conditions | A Single Dose, Two-Period, Two-Treatment, Two-Way Crossover Bioequivalency Study of Calcitriol Tablets, 0.25 mg, Under Fasting Conditions | NCT00601328 |
| Effects of Vitamin D on Renin Expression in Hypertensive Patients | Effects of Calcitriol (1a, 25-[OH]2 Vitamin D3) on Renin Expression in Hypertensive Patients Without Vitamin D Deficiency | NCT00585442 |
| Calcitriol in Combination With Ketoconazole and Therapeutic Hydrocortisone in Treating Patients With Prostate Cancer | A Phase I/II Study of Oral Calcitriol in Combination With Ketoconazole in Androgen Independent Prostate Cancer | NCT00536991 |
| Calcitriol and Dexamethasone in Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy | Phase II Study of Weekly Intravenous 1,25 Dihydroxycholecelciferol (Calcitriol) + Dexamethasone in Androgen Independent Prostate Cancer | NCT00524589 |
| Test if adding Vitamin D, a safe standard vitamin supplement to steroid tablets, will improve the clinical response to steroids in patients who are considered to be steroid resistant | Does 1-alpha,25-dihydroxyvitamin D3 (calcitriol) enhance corticosteroid activity in steroid refractory asthma?A randomised control trial to test whether active vitamin D can improve the clinical response to steroids in asthmatic patients. - Vitamin D and steroid resistant asthma | EUCTR2008-002244-42-GB |
| Vitamin D and Blood Pressure | A Randomized Placebo-controlled Double Blinded Trial to Evaluate Cholecalciferol (Vitamin D3) and Calcitriol Treatment on Reducing Blood Pressure in Middle Aged Adults With Stage I Hypertension and Vitamin D Deficiency | NCT00459563 |
| Long Term Safety and Efficacy Study of Calcitriol 3 mcg/g Ointment in Pediatric Subjects With Plaque Psoriasis | A Multicenter Open Label Uncontrolled Study of the Long Term Safety and Efficacy of Calcitriol 3 mcg/g Ointment Applied Twice Daily for 26 Weeks in Pediatric Subjects (2 to 16 Years and 11 mo of Age) With Mild to Moderate Plaque Psoriasis | NCT02125279 |
| Secondary prevention of type 1 diabetes in children and adolescents aged 6 months - 18 years using oral Vitamin D (calcitriol and analogues) | Secondary PREvention of type 1 diabetes with oral CALcitriol and analogues in children and adolescents aged 6 months - 18 yrs | ISRCTN17354692 |
| A Study to Evaluate Alendronate Sodium /Vitamin D3 Combination Tablets(FOSAMAX PLUS) Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China (MK-0217A-264) | A 6-Month, Randomized, Open-Label, Active-Comparator Controlled, Parallel-Group Study With a 6-Month Extension to Evaluate the Safety and Efficacy of Alendronate Sodium 70 mg/Vitamin D3 5600 I.U. Combination Tablets Versus Calcitriol in the Treatment of Osteoporosis in Postmenopausal Women in China | NCT01350934 |
| Immunointervention With Calcitriol in New-Onset Type 1 Diabetes | Immunointervention With 1,25-dihydroxy-vitamin D3 in New-onset Type 1 Diabetes | NCT00960635 |
